These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 17213460)

  • 61. The effect of cost sharing on the use of chiropractic services.
    Shekelle PG; Rogers WH; Newhouse JP
    Med Care; 1996 Sep; 34(9):863-72. PubMed ID: 8792777
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Breaking through the rhetoric on HMO quality.
    Scofield DL
    Health Cost Manage; 1988; 5(4):8-14. PubMed ID: 10288561
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis confirms pharmacy driving health care cost hikes.
    Capitation Manag Rep; 2001 Jan; 8(1):7-8, 1. PubMed ID: 11209218
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Do HMOs make a difference? Use of health services.
    Tu HT; Kemper P; Wong HJ
    Inquiry; 1999-00 Winter; 36(4):400-10. PubMed ID: 10711315
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HMOs and quality care for HIV -- interview with Stephen Becker, M.D. Part 1 of 2. Interview by John S. James.
    Becker S
    AIDS Treat News; 1997 Sep; (No 278):1-4. PubMed ID: 11364622
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk selection in employer-sponsored managed care plans.
    Marchetta M
    Find Brief; 2005 Sep; 8(5):1-5. PubMed ID: 16145791
    [No Abstract]   [Full Text] [Related]  

  • 68. Dissecting the HMO-benefits managers relationship: what to measure and why.
    Peltier JW; Westfall J
    Mark Health Serv; 2000; 20(2):4-13. PubMed ID: 11183429
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Changes in drug economy in Israel's health maintenance organizations in the wake of the National Health Insurance Law.
    Sax P
    Isr Med Assoc J; 2001 Aug; 3(8):605-9. PubMed ID: 11519388
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alternative insurance arrangements and the treatment of depression: what are the facts?
    Berndt ER; Frank RG; McGuire TG
    Am J Manag Care; 1997 Feb; 3(2):243-50. PubMed ID: 10169258
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Raising the health status of HMO members. Several HMOs are using a statistical model to measure access, morbidity, and utilization.
    Spitzer M; Billings J; Coltin K; Davidson A; Hrdy S
    Bus Health; 1994 Apr; 12(4):80-2, 84, 86-8. PubMed ID: 10133347
    [No Abstract]   [Full Text] [Related]  

  • 72. The determinants of HMO enrollment and growth.
    Goldberg LG; Greenberg W
    Health Serv Res; 1981; 16(4):421-38. PubMed ID: 7327943
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs.
    Benedetto SR; Sloan AS; Duncan BS
    Am J Health Syst Pharm; 2000 Oct; 57(19):1778-85. PubMed ID: 11030030
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The welfare impact of Medicare HMOs.
    Town R; Liu S
    Rand J Econ; 2003; 34(4):719-36. PubMed ID: 14992230
    [TBL] [Abstract][Full Text] [Related]  

  • 75. California HMOs may provide national forecast.
    Coyne JS; Meadows DM
    Healthc Financ Manage; 1991 May; 45(5):34, 36-9. PubMed ID: 10145431
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Provider-owned health plans: El Dorado or Armageddon?
    McCarthy EJ
    Healthc Financ Manage; 1999 Nov; 53(11):35-8. PubMed ID: 11066679
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization.
    Landsman PB; Yu W; Liu X; Teutsch SM; Berger ML
    Am J Manag Care; 2005 Oct; 11(10):621-8. PubMed ID: 16232003
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The making of an HMO city....a case study on the development of HMOs in Detroit.
    Urban Health; 1980 Dec; 9(10):32-7. PubMed ID: 10249887
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HMOs form networks to serve firms with offices in more than one region.
    Kenkel PJ
    Mod Healthc; 1991 Jul; 21(27):37-8. PubMed ID: 10111450
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Controlling prescription drug expenditures: a report of success.
    Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA
    Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.